Delivery Order SPE2DB20D3101-SPE2DB25FQYG3

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,006.22 firm fixed-price delivery order is for the supply of 4,566,407,301 units of Teriparatide 600 mcg/2.4 ml pen with a completion date of November 13, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is a delivery order (SPE2DB20D3101|SPE2DB24FRUX6) for the pharmaceutical product Teriparatide 620 mcg/2.48 ml, 2.48 ml. The contract has a firm fixed price of $4,273.08 and an ultimate completion date of September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing this product under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,676,023 units of the medication Teriparatide 600 mcg/2.4 ml pen in 2.4 ml. The contract is a firm fixed-price Delivery Order with a ceiling value of $8,152.44 and an ultimate completion date of December 11, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $29,830.25 firm fixed-price delivery order is for the supply of 4,566,054,436 units of the drug Teriparatide 600 mcg/2.4 ml pen. The contract has an ultimate completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,312.97, is for the delivery of 620 mcg/2.48 ml teriparatide, a medication used to treat osteoporosis. The contract is a firm fixed-price agreement and is set to expire on October 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $5,429.59 firm fixed price contract is for the delivery of 4564297575 TERIPARATIDE 620 MCG/2.48 ML 2.48ML, a prescription medication. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,198,697 units of the drug Teriparatide 600 mcg/2.4 ml pen. The contract has a ceiling value of $4,419.64 and a completion date of October 25, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $28,089.02 firm fixed price delivery order is for the supply of 4565426630 - TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a broad range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a delivery order valued at $7,717.33 to supply 4,565,068,966 units of the pharmaceutical product teriparatide 600 mcg/2.4 ml pen. The contract has an ultimate completion date of July 5, 2024 and was awarded on July 3, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,230.22 firm-fixed-price delivery order is for the supply of 4,566,760,669 units of the medication teriparatide 600 mcg/2.4 ml pen with a completion date of December 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FQYG3
    Delivery Order

This federal contract award, valued at $8,334.95, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Firm Fixed Price Delivery Order for the supply of 4566833632 - TERIPARATIDE 620 MCG/2.48 ML 2.48ML, with a performance period ending on January 6, 2025. Amerisourcebergen Drug Corp is a for-profit pharmaceutical distribution and healthcare solutions provider that maintains significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for the provision of a wide range of pharmaceutical products and medical supplies to support federal healthcare programs. This specific contract award was not designated with any set-aside requirements, indicating open competition.

Generated 4/4/25, 9:51 AM